Steven Cohen

Last Update: 2015-02-26

Number of Stocks: 644
Number of New Stocks: 262

Total Value: $14,251 Mil
Q/Q Turnover: 53%

Countries: USA
Details: Top Buys | Top Sales | Top Holdings  Embed:

Steven Cohen Watch

  • This Insurer Company Will Have 22 Consecutive Years of Dividend Increases

    In this article, let's take a look at ACE Limited (ACE), a $38.04 billion market cap company, which is a specialty insurer that provides commercial insurance and reinsurance for a diverse group of international clients.


    New dividend proposal

      


  • David Dreman bets on Barnes Group Inc.

    David Dreman (Trades, Portfolio) is the founder and chairman of Dreman Value Management, LLC and also serves as the firm's chief investment officer. A regular columnist for Forbes for 25 years, Mr. Dreman's recent best-selling book, "Contrarian Investment Strategies: The Next Generation?" was published in the spring of 1998. Three years back, in 2012, he published his last book, “Contrarian Investment Strategies: The Psychological Edge."


    The contrarian and the value guru, Dreman's investment philosophy is based on low P/E approach to stock selection. The philosophy at Dreman Value Management: "We invest in undervalued companies that exhibit strong fundamentals, above-market dividend yields and historic earnings growth, which our analysis indicates will persist. Our strategy is to own strong, fundamentally sound companies and to avoid speculative stocks or potential bankruptcies." They believe that the markets are not perfectly efficient and that behavioral psychology influences investor actions and reactions.

      


  • ADS: Earnings Keep Growing, But the Price Remains Range-Bound

    You may not know the name, but this company likely knows you, or at least the details of your spending. It gathers all kinds of data about our buying, works with and makes sense of that information, and then passes it along to its clients. Those clients, in turn, can personalize the offers they make to us in retail and other arenas.


    Alliance Data Systems Corporation (ADS) deals in credit cards obviously, loyalty cards, and more. It’s part of the new world of digital or data marketing that has made huge strides in the past few decades.

      


  • This Paint and Coatings Company Has 36 Consecutive Years of Dividend Increases

    In this article, let's take a look at The Sherwin-Williams Company (SHW), a $27.87 billion market cap company that is engaged in the development, manufacture, distribution and sale of paints, coatings and related products to professional, industrial, commercial and retail customers worldwide.


    Dividend hike

      


  • Why Investors Should Buy this Milwaukee-Based Company

    In this article, let's take a look at Harley-Davidson, Inc. (HOG), a $13.69 billion market cap company that is a leading maker of heavyweight motorcycles also produces a line of motorcycle parts and accessories.


    New CEO

      


  • Steven Cohen Buys Stake in Company Looking For Buyer

    Steven Cohen (Trades, Portfolio)’s fund Point72 picked up its second large holding of the year, this time of Healthways Inc. (HWAY). Cohen purchased 2,316,700 shares of the company on Jan. 26, equating to 6.55% of the company, according to GuruFocus Real Time Picks.


    On Jan. 22, Cohen reported a 5.89% stake in drug company Five Prime Therapeutics Inc. (FPRX).

      


  • Investors Should Consider Xilinx

    In this article, let's take a look at Xilinx Inc. (XLNX), a $10.43 billion market cap company that is one of the world's leading suppliers of programmable logic chips and related development system software.


    Market share

      


  • Steven Cohen Buys New Drug Stock, Triples Stake in Medical Company

    Steven Cohen (Trades, Portfolio)’s Point72 Asset Management, freshly named from its previous title SAC Capital Advisors when it converted to a family office last year, has purchased a sizable stake in a new stock and tripled its holding of another, reported GuruFocus Real Time Picks.


    Cohen purchased a 5.89% stake in Five Prime Therapeutics Inc. (FPRX), consisting of 1,260,352 shares, on Jan. 22. Five Prime, a medical therapeutics company, saw its shares rise 35% in the past year, closing at $24.95 per share on Friday.

      


  • 4 Stocks Steven Cohen Is Buying

    Steven Cohen (Trades, Portfolio) rebranded his former hedge fund, SAC Capital, as Point72 Asset Management, a family office managing his and some of his employees’ assets, after paying fines for insider trading last year. The firm focuses on long-short equities and quantitative and macro investments, and it was quite successful last year, with gross profit of $2.5 billion to $3 billion, the New York Times reported.


    Point72 also actively traded on the last day of the 2014, adding shares to stakes they already owned in nine companies. These were the largest: Kindred Healthcare (KND), Walter Investment Management (WAC), RCS Capital Corp (RCAP) and Shutterfly Inc. (SFLY).

      


  • Steven Cohen Buys Stake in Texas Oil Company

    Steven Cohen (Trades, Portfolio) has invested in a Texas-based oil and gas company, Jones Energy Inc. (JONE), according to GuruFocus RealTime Picks.  


  • Following Steven Cohen and Steve Mandel

    In this article let's take a look at the intrinsic value and try to compare it with the current stock price in the case of Williams Companies, Inc. (WMB), a $31.5 billion market cap company whose primary focus is to connect North America's hydrocarbon resource plays to growing markets for natural gas, NGLs and olefins.


    Not so bright

      


  • A Strong Sell Recommendation?

    In this article, let's take a look at Dominion Resources, Inc. (D), a $42.03 billion market cap company, which is one of the largest producers and transporters of energy in the U.S., Further, it operates the largest natural gas storage system and serves retail energy customers in 15 states.


    Virginia´s Threat

      


  • CH Robinson Worldwide Has Plenty of Room to Grow

    In this article, let's take a look at CH Robinson Worldwide Inc. (CHRW), a $10.64 billion market cap company that is a global provider of multimodal transportation and logistics solutions and has a network of more than 230 offices in North America, South America, Europe and Asia.


    Business model

      


  • T Rowe Price's Top Stakes for the Third Quarter

    In recent days hedge funds have been filing form 13-F, which is a quarterly report of equity holdings by filed institutional investment managers with at least $100 million in equity assets under management, as required by the United States Securities and Exchange Commission (SEC). In this article, let´s concentrate in one particular hedge fund and try to see the principal holdings in its portfolio. I will look into T Rowe Price Associates Inc.


    Recently, the fund reported its equity portfolio ended September. The total value of the portfolio amounted to $457.5 billion, down from $461.6 million disclosed at the end of the previous quarter. Consequently, the fund's equity market change value was negative 4.1 million in the last quarter. The filing revealed that at the end of September, the fund added 88 new positions to its equity portfolio and sold out 73 positions. The top ten portfolio holdings as of the end of the quarter represented 12.09%. The largest changes from previous 13-F´s fillings are in the Health Care and Consumer Discretionary sectors.

      


  • This Stock Price Remains Flat

    In this article, let's take a look at Hormel Foods Corporation (HRL), a $13.89 billion market cap Ohio-based company that spun off from NCR Corp. in 2007. Hormel Foods has global operations focused on data warehousing and enterprise analytics.


    Brand recognition

      


  • Another 'Buy Reason' for this Potash Company

    In a previous article, we analyze quantitative aspects of Potash Corp. of Saskatchewan, Inc. (POT), a $30.39 billion market cap company. Now, in this article let's take a look at the intrinsic value and try to compare it with the current stock price.


    Dividend policy

      


  • You Should Hold Merck According to Dividends Generation

    In this article, let's take a look at Merck & Co. Inc. (MRK), a $169.28 billion market cap company, which is one of the world's largest drug makers, acquired Schering-Plough in November 2009.


    Returning value to shareholders

      


  • Gotham's Top Stakes for the Third Quarter

    Over the past days hedge funds have been filing their form 13-F, which is a quarterly report of equity holdings by filed institutional investment managers with at least $100 million in equity assets under management, as required by the United States Securities and Exchange Commission (SEC). In this article, let´s concentrate in one particular hedge fund and try to see the principal holdings in its portfolio. I will look into Gotham Asset Management LP, whose founder is the value investor Joel Greenblatt (Trades, Portfolio).


    Recently, the fund reported its equity portfolio ended September. The total value of the portfolio amounted to $10.04 billion, up from $7.9 million disclosed at the end of the previous quarter. Consequently, the fund's equity market change value was 2.0 million in the last quarter. The filing revealed that at the end of September, the fund added one new position to its equity portfolio and sold out one position. The top ten portfolio holdings as of the end of the quarter represented 7.23%. The largest changes from previous 13-F´s fillings are in the Health Care and Industrial sectors.

      


  • Lumber Liquidator CEO Purchases Shares, Stock Rises

    Now could be the time to consider a position in Lumber Liquidators (LL) — President and CEO Robert Lynch may be on a buying spree, after purchasing 4,000 shares of the company on Oct. 29, and 2,000 shares on Nov. 4.


    While insider buying is always a good sign, according to Peter Lynch in his bestselling book “One Up on Wall Street,” what sets Lumber Liquidators apart is Lynch’s track record over the years. It’s clear the CEO has good timing when it comes to buying and selling the stock — from 2011 to 2012, all of Lynch’s recorded transactions were buys, which caused the stock to increase more than 100% on seven out of nine occasions. In August 2011, the stock rose more than 307% after Lynch purchased 2,000 shares of the company.

      


  • Ebola Diagnosis in U.S. Raises Pharmaceutical Stock by 20%

    Shares of Tekmira Pharmaceuticals (TKMR), which currently has an Ebola treatment in the early stages, soared more than 20% after the first case of Ebola in the U.S. was diagnosed in Dallas on Sept. 30.


    Tekmira’s stock price has increased more than 250% since the beginning of the year and is currently trading at $25.59. The trading volume was more than 13 million, far higher than Tekmira's average trading volume of about 133,000.

      


Add Notes, Comments

If you want to ask a question, or report a bug, please create a support ticket.

User Comments

No comment yet



Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
Free 7-day Trial
FEEDBACK